Preethi Sundaram
Chief Tech/Sci/R&D Officer at SANOFI
Net worth: 374 942 $ as of 30/04/2024
Network origin in Preethi Sundaram first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
32
| Public Company | Biotechnology | 32 |
| Public Company | Pharmaceuticals: Major | 20 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Preethi Sundaram via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Masters Business Admin | |
| CAPGEMINI SE | Information Technology Services | Director/Board Member Director of Finance/CFO | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | General Counsel Chief Executive Officer | |
| SOCIÉTÉ GÉNÉRALE | Regional Banks | Chief Executive Officer Corporate Officer/Principal | |
| University of Maryland | College/University | Masters Business Admin Undergraduate Degree | |
Capgemini Italia SpA
 Capgemini Italia SpA Miscellaneous Commercial ServicesCommercial Services Capgemini Italia SpA provides consultancy and technology services. It offers artificial intelligence, business operations, technology and cloud services. The firm serves automotive, insurance, banking, and telecom sectors. The company was founded by Serge Kampf in 1967 and is headquartered in Rome, Italy. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Capgemini Service SAS
 Capgemini Service SAS Data Processing ServicesTechnology Services Capgemini Service SAS provides, technology and outsourcing services. The company was founded in 1965 and is headquartered in Paris, France. | Data Processing Services | Director/Board Member Director/Board Member | |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal Comptroller/Controller/Auditor | |
Capgemini Technology Services India Ltd.
 Capgemini Technology Services India Ltd. Information Technology ServicesTechnology Services Capgemini Technology Services India Ltd. provides information technology and business process outsourcing services. It provides customized and packaged application development, application maintenance outsourcing, business intelligence services and application re-engineering through offshore development centers. The company was founded on December 27, 1993 and is headquartered in Pune, India. | Information Technology Services | Director/Board Member Director of Finance/CFO | |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services University of Miami (Florida) is a private research university with students from around the world that is focused on teaching and learning, the discovery of new knowledge, and service to the South Florida region and beyond. The university was founded in 1925 and it is headquartered in Coral Gables, FL. | College/University | Graduate Degree Doctorate Degree | |
Royce Laboratories, Inc.
 Royce Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., Royce Laboratories, Inc. is a company that develops, makes, and sells generic drugs. The company is based in Miami, FL. Royce Laboratories was acquired by Actavis, Inc. on April 17, 1997 for $98.01 million. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| L'ORÉAL | Household/Personal Care | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| Ecole Polytechnique | College/University | Undergraduate Degree Director/Board Member | |
| DANONE | Food: Meat/Fish/Dairy | Director/Board Member Chairman | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| THERMOGENESIS HOLDINGS, INC. | Medical Specialties | Chief Executive Officer Director/Board Member | |
| University of Wisconsin | College/University | Masters Business Admin Masters Business Admin | |
Linklaters LLP
 Linklaters LLP Miscellaneous Commercial ServicesCommercial Services Linklaters LLP provides legal services. It provides services in the areas such as banking, insurance, intellectual property, pensions, private equity, real estate and tax. The firm's clients include China International Capital, Novolipetsk Steel, Old Mutual and Richardson Cordwell. The company was founded in 1837 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Sitryx Therapeutics Ltd.
 Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Medical Specialties | Founder | |
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Investment Managers | Private Equity Investor | |
| CINCOR PHARMA, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| University of Oxford | College/University | Undergraduate Degree | |
| INHIBRX, INC. | Biotechnology | President | |
| IPI LEGACY LIQUIDATION CO | Pharmaceuticals: Major | Director of Finance/CFO | |
| University of Freiburg | College/University | Doctorate Degree | |
| King's College London | College/University | Graduate Degree | |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | College/University | Corporate Officer/Principal | |
Actavis Group hf
 Actavis Group hf Pharmaceuticals: MajorHealth Technology Actavis Group hf develops, manufactures and sells generic pharmaceuticals. The company was founded in 1957 and is headquartered in Hafnarfjörður, Iceland. | Pharmaceuticals: Major | General Counsel | |
Universitätsklinikum Freiburg
 Universitätsklinikum Freiburg Hospital/Nursing ManagementHealth Services Universitätsklinikum Freiburg operates as a teaching hospital. The company was founded by Archduke Albrecht VI in 1457 and is headquartered in Freiburg, Germany. | Hospital/Nursing Management | Corporate Officer/Principal | |
| ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| VEOLIA ENVIRONNEMENT | Water Utilities | Public Communications Contact | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
WellSky Corp.
 WellSky Corp. Information Technology ServicesTechnology Services WellSky Corp. develops, implements and supports clinical management information systems. The firm?s services include advisory, outsourced and professional services. It also offers cellular therapy, blood transfusion and donation, home care, hospice, donor testing, blood centres, medication management, human services, rehabilitation, respiratory service and scheduling services. The company was founded in 1980 and is headquartered in Overland Park, KS. | Information Technology Services | Director/Board Member | |
Ervaxx Ltd.
 Ervaxx Ltd. Pharmaceuticals: MajorHealth Technology Ervaxx Ltd. is a British company that pioneers the use of dark antigens to deliver targeted immunotherapies for treating and preventing cancer. The company was founded in 2016 by George Kassiotis, Drew M. Pardoll and is based in London, UK. The company's powerful, proprietary edapt platform has been developed to discover and validate dark antigens providing an in-depth assessment of candidate antigens on primary tumor cells along with their immunogenic potential. Ervaxx is advancing a pipeline of T cell receptor-based therapies, off-the-shelf cancer vaccines, and other immunotherapies leveraging these insights into the role of dark antigens in cancer. | Pharmaceuticals: Major | Director/Board Member | |
Imbria Pharmaceuticals, Inc.
 Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
Spotlight Therapeutics, Inc.
 Spotlight Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Spotlight Therapeutics, Inc. engages in gene editing therapeutics. It focused in reprogramming tumor microenvironment. The company was founded by Alex Marson, Patrick Hsu, and Jacob Corn in 2017 and is headquartered in Hayward, CA. | Pharmaceuticals: Generic | Director/Board Member | |
| Université Paris-Saclay | College/University | Doctorate Degree | |
| CENTESSA PHARMACEUTICALS PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| DAIICHI SANKYO CO., LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Catamaran Bio, Inc.
 Catamaran Bio, Inc. Financial ConglomeratesFinance Catamaran Bio, Inc. provides investment services. The company is headquartered in Delaware. | Financial Conglomerates | Founder | |
| Enara Bio Ltd. | Biotechnology | Founder | |
Dualitas Ltd.
 Dualitas Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Envisics LLC, Dualitas Ltd. is a British company that engages in developing technologies to deliver holographic and augmented reality products and services. The company is based in London, UK. The company was founded in 2016 by Houman Ashrafian. | Miscellaneous Commercial Services | Founder | |
Weatherden Ltd.
 Weatherden Ltd. BiotechnologyHealth Technology Weatherden Ltd. is a pioneering clinical development consulting group based in London, UK. The British company specializes in scientific strategy, translational medicine, clinical development, diligence preparation, and support for M & A. Weatherden focuses on de-risking programs early and optimizing clinical, regulatory, and commercial pathways to bring life-changing medicines to patients. With over 750 years of combined industry experience, they are dedicated to improving the chances for breakthrough therapies to address unmet clinical needs. The private company, founded by Duncan McHale and Houman Ashrafian, provides trusted advice to biopharma, funds, startups, spin-outs, and nonprofits. Emma Tinsley has been the CEO of the company since 2017. | Biotechnology | Founder | |
| University of Cambridge | College/University | Graduate Degree | |
Therini Bio, Inc.
 Therini Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Therini Bio, Inc. engages in research and development in the field of biotechnology. The company was founded by Katerina Akassoglou in 2016 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Chairman | |
Prilenia Therapeutics BV
 Prilenia Therapeutics BV BiotechnologyHealth Technology Prilenia Therapeutics BV develops and manufactures pharmaceuticals. The company was founded in 2018 and is headquartered in Naarden, the Netherlands. | Biotechnology | Director/Board Member | |
SV Health Managers LLP
 SV Health Managers LLP Investment ManagersFinance SV Health Managers LLP (SVHM) is the investment management subsidiary of SV Life Sciences Advisers LLP in the UK. Established in 2005, the firm was formerly known as SV Life Sciences Managers LLP and changed their name to SV Health Managers LLP in 2017. Based in London, the firm manages the International Biotechnology Trust plc (LSE: IBT), an investment trust vehicle listed on the London Stock Exchange into which corporate and private investors may invest. | Investment Managers | Portfolio Manager-Equities |
Statistics
International
| United States | 20 |
| United Kingdom | 14 |
| France | 10 |
| Germany | 3 |
| Italy | 2 |
Sectoral
| Health Technology | 22 |
| Consumer Services | 12 |
| Commercial Services | 7 |
| Technology Services | 5 |
| Finance | 5 |
Operational
| Director/Board Member | 178 |
| Corporate Officer/Principal | 86 |
| Chairman | 65 |
| Independent Dir/Board Member | 43 |
| Chief Executive Officer | 38 |
Most connected contacts
| Insiders | |
|---|---|
| Gilles Schnepp | 60 |
| Carole Ferrand | 30 |
| Patrick Kron | 28 |
| Fabienne Lecorvaisier | 27 |
| Lise Kingo | 23 |
| Houman Ashrafian | 22 |
| David Tierney | 19 |
| Frédéric Oudéa | 15 |
| Richard Daly | 15 |
| Philip Coelho | 13 |
| Olivier Antoine M. Charmeil | 12 |
| Rachel Duan | 11 |
| Gary Ingenito | 10 |
| Paul Hudson | 10 |
| Donald Denkhaus | 10 |
- Stock Market
- Insiders
- Preethi Sundaram
- Company connections
